This inventor holds 11 USPTO granted patents and 1 published patent application. Top assignees: Advanced Peptides & Biotechnology Sciences, Advanced Immuni T, Inc., Rapid Pharmaceuticals Ag. Active years: 1995-2018.
Company Filing History:
3 out of 3 
2 out of 4 
2 out of 2 Years Active: 1995-2018
Title: **Candace B Pert: Innovator in Pain Management and Therapeutic Peptides**
Introduction
Candace B Pert, based in Potomac, MD, is a notable inventor with a focus on developments in the field of pain management and therapeutic peptides. With a remarkable portfolio of 11 patents, he has made significant contributions to the medical and biotechnology sectors, particularly in addressing chronic pain and inflammatory diseases.
Latest Patents
One of Pert's latest patents involves a modified peptide designed to reduce pain in peripheral neuropathy. His research highlights the role of chemokine signaling in neuropathic pain, particularly emphasizing the involvement of microglial cells that express CCR2. Through his work with DAPTA, a CCR5 entry-inhibitor, Pert revealed that a stabilized analog called All D TTNYT (SEQ ID NO:1) exhibits significant antagonism for both CCR2 and CCR5. His findings demonstrate that oral administration of this peptide not only prevents mechanical allodynia but also reverses established hypersensitivity. This dual antagonism may offer enhanced efficacy for treating neuropathic pain, suggesting broad clinical applications.
Career Highlights
Throughout his career, Candace B Pert has been affiliated with reputable firms such as Advanced Peptides & Biotechnology Sciences, where he has leveraged his expertise to advance therapeutic solutions. His prolific work has positioned him as a key figure in the innovation landscape of medical treatment for various inflammatory conditions.
Collaborations
Pert has collaborated with notable colleagues, including Michael R Ruff and Joanna M Hill. These partnerships reflect his commitment to interdisciplinary research and the collective effort to drive forward scientific advancements.
Conclusion
Candace B Pert's innovative contributions underscore his vital role in the development of therapies for managing pain and inflammatory diseases. As his work continues to evolve, he remains a significant force in the quest for effective treatments, demonstrating the potential for his peptides and therapies to impact patients’ lives positively.